Research Education Sport Leisure and Travel

Have you got a story or article?

Click Here

Newsletter Subscription

Sign up for E-mail News

Featured Articles

Guide dog has given ex-footballer his life back – Guide Dogs

Access to life – DisabledGo Blog

DPOs join forces to brief UN on how UK has breached disability convention – DisabledGo Blog

Prescriptions to rise by 20p in England – BBC News

‘Huge advance’ in fighting world’s biggest killer – BBC News

Activists bring ‘no more benefit deaths’ message to Westminster – DisabledGo Blog

Local people get involved in updating The Dundee Accessibility Checker – DisabledGo Blog

Meet “Wheelchair Man,” the First Afghan-American Superhero – New Mobility Magazine

New autism test can detect disorder years earlier – Daily Mail Online

Disabled peer says Mordaunt was ‘spinning like crazy’ over PIP cuts – DisabledGo Blog

The new ‘normal’: adapting to disability later in life – Disability Horizons

GlassOuse assistive technology review and chance to WIN the £330 glasses – Disability Horizons

M&S launches mental health drop-ins as part of Ruby Wax project – The Guardian

DWP ‘tells disability benefits assessors to discriminate against people with mental health conditions’ – Independent

Spring budget: New free schools funding ‘shows utter disregard for human rights’ – DisabledGo Blog

Ataxia

September 25, is International Ataxia Awareness Day. Chances are you won’t have […]

The selective degeneration of certain neurons in patients with Friedreich’s ataxia may […]

A case report suggests that Friedreich’s ataxia can manifest as abnormal voluntary […]

This report provides comprehensive information on the therapeutic development for Friedreich Ataxia, […]

The Illinois Biotechnology Industry Organization (iBIO) recently announced that Kyle Bryant, founder […]

RaNA Therapeutics, a Cambridge, Massachusetts-based biotech company that develops next-generation RNA-targeted medicines […]

Recently, mutations in transmembrane protein 240 (TMEM240) were identified as the cause […]

Chondrial Therapeutics recently announced that further development of its lead drug candidate […]

Avalanche Biotechnologies, based in Menlo Park, California, is a gene therapy company […]

CAT-4001 is being developed by Catabasis as a potential treatment for neurodegenerative […]